Article
Additive effect of GHRd3 and COLIA1 polymorphisms on the GH-substitution dose in GH-deficient adults.
Pharmacogenomics - 1 Dec 2011
Hartleb Silke, Plöckinger Ursula, Stalla Günter K, Tuschy Ulrich, Weber Matthias M, Pfützner Andreas, Kann Peter Herbert
Abstract excerpt
UNLABELLED: The exon 3-deleted/full-length growth hormone receptor (GHRd3) polymorphism and the collagen type Iα 1-specific protein 1 (COLIA1) polymorphism have each recently been linked to the responsiveness to recombinant growth hormone (GH) treatment in GH-deficient adults. In this context, one or two GHRd3 alleles and the homozygous COLIA1 TT genotype were each associated with a significantly lower GH dose....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
